Melis Gonulal

Izmir, Turkey

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Darier disease-A review highlighting new insights from the Darier Disease International Task Force.

Darier disease-A review highlighting new insights from the Darier Disease International Task Force.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: November 24, 2025

Myosteatosis as a metabolic risk in hidradenitis suppurativa: a CT-based study.

Myosteatosis as a metabolic risk in hidradenitis suppurativa: a CT-based study.

Journal: Frontiers in medicine
Published: October 05, 2025

Analysis of factors influencing target PASI responses and side effects of methotrexate monotherapy in plaque psoriasis: a multicenter study of 1521 patients.

Analysis of factors influencing target PASI responses and side effects of methotrexate monotherapy in plaque psoriasis: a multicenter study of 1521 patients.

Journal: Archives of dermatological research
Published: January 06, 2024

Risankizumab for the Treatment of the Patients with Moderate to Severe Plaque Psoriasis During a 24-Week Period: Real-Life Experience.

Risankizumab for the Treatment of the Patients with Moderate to Severe Plaque Psoriasis During a 24-Week Period: Real-Life Experience.

Journal: Clinical, cosmetic and investigational dermatology
Published: October 19, 2023

Keratosis Pilaris Atrophicans Faciei: A Case Treated with 585 nm Diode Laser, a Novel Fractional Solid-State.

Keratosis Pilaris Atrophicans Faciei: A Case Treated with 585 nm Diode Laser, a Novel Fractional Solid-State.

Journal: Clinical, cosmetic and investigational dermatology
Published: October 13, 2023

Dermoscopic Features of Cutaneous Vasculitis.

Dermoscopic Features of Cutaneous Vasculitis.

Journal: Dermatology practical & conceptual
Published: August 26, 2023

Effectiveness and safety of ustekinumab for the treatment of psoriasis; six years of clinical experience.

Effectiveness and safety of ustekinumab for the treatment of psoriasis; six years of clinical experience.

Journal: The Journal of dermatological treatment
Published: August 03, 2023

Real-life efficacy and drug continuation of secukinumab in treating moderate to severe plaque psoriasis in Aegean region of Turkey: a multicenter retrospective study and systematic review of the literature.

Real-life efficacy and drug continuation of secukinumab in treating moderate to severe plaque psoriasis in Aegean region of Turkey: a multicenter retrospective study and systematic review of the literature.

Journal: Asian Pacific journal of allergy and immunology
Published: October 24, 2022

Ixekizumab for the treatment of the patients with moderate to severe plaque psoriasis: Clinical data from a real-world experience.

Ixekizumab for the treatment of the patients with moderate to severe plaque psoriasis: Clinical data from a real-world experience.

Journal: Dermatologic therapy
Published: August 26, 2022

Internalized Stigma in Hidradenitis Suppurativa: A Multicenter Cross-Sectional Study.

Internalized Stigma in Hidradenitis Suppurativa: A Multicenter Cross-Sectional Study.

Journal: Dermatology (Basel, Switzerland)
Published: August 05, 2022

The impact of COVID-19 pandemic on psoriasis patients, and their immunosuppressive treatment: a cross-sectional multicenter study from Turkey.

The impact of COVID-19 pandemic on psoriasis patients, and their immunosuppressive treatment: a cross-sectional multicenter study from Turkey.

Journal: The Journal of dermatological treatment
Published: May 25, 2021

Clinical characteristics, quality of life and risk factors for severity in palmoplantar pustulosis: a cross-sectional, multicentre study of 263 patients.

Clinical characteristics, quality of life and risk factors for severity in palmoplantar pustulosis: a cross-sectional, multicentre study of 263 patients.

Journal: Clinical and experimental dermatology
Published: May 22, 2021
Showing 1-12 of 14

Last Updated: 09/26/2026